Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Not applicableNot Yet RecruitingNCT07703644
What this trial is testing

Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients

Who this might be right for
Hematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more
Sizhou Feng 60
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Not applicableStudy completedNCT03103308
What this trial is testing

Hematopoetic Stem Cell Transplant and Physical Function

Who this might be right for
CancerWalking
University of Miami 25
Testing effectiveness (Phase 2)Study completedNCT04061876
What this trial is testing

First Line Therapy for High Risk Acute GVHD

Who this might be right for
aGVHDStem Cell Transplant Complications
Chinese PLA General Hospital 198
Testing effectiveness (Phase 2)UnknownNCT01807468
What this trial is testing

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaRhabdomyosarcoma+2 more
Samsung Medical Center 12
Early research (Phase 1)UnknownNCT01615250
What this trial is testing

Implantation of Peripheral Stem Cells in Patient With Ischemic Cardiomyopathy

Who this might be right for
Heart Failure
Odessa National Medical University 50
Testing effectiveness (Phase 2)Study completedNCT02249676
What this trial is testing

Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Devic's SyndromeDevic's Neuromyelitis OpticaDevic Syndrome+2 more
Tianjin Medical University General Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06364774
What this trial is testing

ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Who this might be right for
Beta-Thalassemia
Children's Hospital of Philadelphia 12
Testing effectiveness (Phase 2)UnknownNCT03876197
What this trial is testing

Mesenchymal Stem Cells for Radiation-induced Xerostomia

Who this might be right for
Radiation ToxicityXerostomia Due to RadiotherapyDry Mouth+4 more
Rigshospitalet, Denmark 30
Testing effectiveness (Phase 2)Study completedNCT02356159
What this trial is testing

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
National Cancer Institute (NCI) 34
Large-scale testing (Phase 3)UnknownNCT03295058
What this trial is testing

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Who this might be right for
Severe Aplastic Anemia
Assiut University 50
Early research (Phase 1)Study completedNCT01771640
What this trial is testing

Intrathecal Transplantation of Mesenchymal Stem Cell in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Royan Institute 8
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2
Testing effectiveness (Phase 2)Study completedNCT00802113
What this trial is testing

Autologous and Allogeneic Transplant for Relapsed Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaHodgkins Disease
Columbia University 30
Very early researchLooking for participantsNCT06787560
What this trial is testing

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

Who this might be right for
Bone Marrow Failure Syndrome
Zhejiang University 20
Testing effectiveness (Phase 2)Study completedNCT05701215
What this trial is testing

Venetoclax After TKI to Target Persisting Stem Cells in CML

Who this might be right for
Chronic Myeloid Leukemia
Thomas Ernst, PD Dr. med. 10
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Next Page